Biogen Inc. (BIIB)

Overview Products Trials

Market Cap	$22.78B
Revenue TTM
Earnings Date	2025-02-11
Website	https://www.biogen.com

Upcoming PDUFA Dates

No upcoming PDUFAs found

Upcoming Trial Readouts

Feature coming soon

Upcoming Patent Expirations

Brand Name	Patent Number	Expire Date
SPINRAZA	10266822	12/5/2025
SPINRAZA	8110560	12/5/2025
Tysabri	10,705,095	4/4/2026
Tysabri	9,709,575	4/4/2026
Tysabri	8,871,449	4/12/2026
Tysabri	10,233,245	2/28/2027
Tysabri	11,292,845	2/28/2027
Tysabri	9,493,567	3/5/2027
SPINRAZA	7838657	7/11/2027
Tysabri	8,124,350	8/2/2027
TECFIDERA	8399514	2/7/2028
Tysabri	9,696,307	2/5/2030
SPINRAZA	9717750	6/17/2030
Tysabri	9,005,926	10/1/2030
SPINRAZA	8980853	11/24/2030
Tysabri	9,212,379	11/28/2030
SPINRAZA	8361977	12/23/2030
Tysabri	9,096,879	1/7/2031
Tysabri	10,444,234	1/11/2031
Tysabri	11,287,423	1/11/2031
Tysabri	8,318,416	1/20/2031
Tysabri	10,308,706	2/5/2031
Tysabri	8,809,049	5/22/2031
Tysabri	9,109,015	8/13/2031
Tysabri	9,316,641	1/9/2032
Tysabri	10,590,454	5/11/2032
Tysabri	9,790,533	5/11/2032
Tysabri	9,562,252	5/11/2033
VUMERITY	10080733	9/20/2033
VUMERITY	8669281	9/20/2033
VUMERITY	9090558	9/20/2033
SPINRAZA	9926559	1/9/2034
ZURZUVAE	10172871	4/17/2034
ZURZUVAE	10342810	4/17/2034
ZURZUVAE	9512165	4/17/2034
Tysabri	10,119,976	5/27/2034
Tysabri	10,677,803	5/27/2034
Tysabri	11,280,794	5/27/2034
Tysabri	10,676,772	8/19/2034
Tysabri	9,994,968	8/19/2034
TECFIDERA	10391160	3/13/2035
TECFIDERA	10555993	3/13/2035
TECFIDERA	10994003	3/13/2035
Tysabri	10,023,831	3/17/2035
QALSODY	10385341	4/1/2035
QALSODY	10669546	4/1/2035
QALSODY	10968453	4/1/2035
Tysabri	11,124,760	8/27/2035
SPINRAZA	10436802	9/11/2035
TECFIDERA	10959972	11/16/2035
TECFIDERA	11007166	11/16/2035
TECFIDERA	11007167	11/16/2035
TECFIDERA	11129806	11/16/2035
TECFIDERA	11246850	11/16/2035
Tysabri	11,268,119	2/21/2036
SPINRAZA	12013403	3/4/2036
Tysabri	10,844,416	6/1/2036
ZURZUVAE	11236121	8/23/2037
ZURZUVAE	11884696	12/24/2037